Trials Consider Role of Immunotherapy in Breast Cancer

Trials Consider Role of Immunotherapy in Breast Cancer

2018-03-29 10:16:32

Mixed results have occured in recent trials testing immuotherapy in patients with breast cancer. Checkpoint inhibitors have been used as monotherapy in a pair of trials, reporting lackluster overall response rates. When immunotherapy was paired with chemotherapy, on the other hand, it usually revealed better results, and gave signals that immunotherapies combined with targeted agents could work better than immunotherapy alone.

Source

pharma digital marketing

Pharma Digital Marketing: Lackluster or Blockbuster?

Pharmaceutical companies are not delivering the online content physicians consider supportive in better patient management. This was concluded by a survey among 2,784 U.S. physicians across 25+ different specialities. Only 27% agreed that pharma websites are a credible source of information.